Prohias MJA, Luperon LD, López GA, Claro VR

Language: Spanish
References: 19
Page: 1-5
PDF size: 150.08 Kb.

ABSTRACT

The mortality of cancer patients has been significantly reduced due to advances in early diagnosis and cancer treatment. However, in order to improve the prognosis, complications arising from cancer treatments should be prevented, diagnosed and treated through the creation of multidisciplinary teams between oncologists and cardiologists. The experience of cardioncology in the Hnos. Ameijeiras Hospital is presented as an organizational model in a tertiary hospital potentially applicable to secondary hospitals in the country with its results in the diagnosis and treatment of cardiotoxicity and in the monitoring of cancer survivors.

REFERENCES

1. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977–1010.

2. Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet. 2014;383:549–557.

3. Freeman AM, Herrmann J, Iliescu C, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015; 65:2739–2746.

4. Fiuza M, Ribeiro L, Magalhães A, et al. Organization and implementation of a cardio-oncology program. Rev Port Cardiol. 2016; 35(9):485-94.

5. Barros-Gomes S, Herrmann J, Mulvagh SL, Lerman A, Lin G, Villarraga HR. Rationalefor setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardio-Oncology. 2016; 2:1–9.

6. Mehta LS,Watson K E, Barac A et al: Cardiovascular disease and breast cancer Where these entities Intersect. Circulation. 2018; 137: e1-e35.

7. Gujral DM, Manisty C, Lloyd G, et al. Organisation & models of cardio oncology clinics. Int J Cardiol 2016; 214:381–2.

8. Sulpher J, Mathur S, Graham N, et al. Clinical experience of patients referred to a multidisciplinary Cardiac Oncology Clinic: an observational study. J Oncol. 2015; 671232.

9. Okwuosa T, Barac A. Burgeoning cardio-oncology programs: challenges and opportunities for early career cardiologists/faculty directors. J Am Coll Cardiol. 2015; 66:1193.

10. Snipelisky D,Yoon Park J, Lerman A et al. How to develop a cardioncology clinic. Heart Failure Clin. 2017; (13) 347-359.

11. Lopez Fernandez T, Martin Garcia A, Santaballa Beltran A et al. Cardio-Onco-Hematologia en la práctica clínica. Rev Esp Cardiol 2017; 70(6)474-486.

12. Pavo N, Raderer M, Hülsmann M, et al. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Heart. 2015;101:1874–1880.

13. Wang L, Tan TC, Halpern EF, et al. Major cardiac events and the value of echocardiographic evaluation in patients receiving anthracycline-based chemotherapy. Am J Cardiol. 2015;116:442–446.

14. Parent S, Pituskin E, Paterson DI. The cardio-oncology program: a multidisciplinary approach to the care of cancer patients with cardiovascular disease. Can J Cardiol. 2016; 32:847–851.

15. Lenihan DJ, Hartlage G, DeCara J, et al. Cardio-oncology training: A proposal from the international cardioncology society and canadian cardiac oncology network for a new multidisciplinary specialty. J Card Fail. 2016; 22:465–471.

16. Al-Kindi SG, Oliveira GH. Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology. Mayo Clin Proc. 2016;91:81–83.

17. Barac A, Murtagh G, Carver JR, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015; 65: 2739–46.

18. Herrmann J, Yang EH, Iliescu CA, et al. Vascular toxicities of cancer therapies: The old and the new – an evolving avenue. Circulation. 2016; 133:1272–1289.

19. Lenneman CG, Sawyer DB. Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res. 2016; 118:1008–1020.